Bronx, New York 10461


This randomized clinical trial aims to examine the effect of a standardized 8-week course of Mindfulness Based Cognitive Therapy for Migraine on migraine-related disability in people with migraine.


Inclusion Criteria: - ICHD-3 beta headache diagnosis of migraine, - self-reported and diary-confirmed 4-20 headache days per month - aged 18-65 - ability to read English - capacity to consent. Exclusion Criteria: - no ICHD-3 beta headache diagnosis of migraine - fewer than 4 or greater than 20 headache days per month - under 18 or over 65 - inability to read English - lacking the capacity to consent - utilization of new preventative pain treatments within four weeks of the baseline assessment, or a plan to utilize new preventive pain medications during the duration of the study - severe psychiatric illness that would interfere with participation in the treatment



Primary Contact:

Principal Investigator
Elizabeth K Seng, Ph.D.
Yeshiva University/Albert Einstein College of Medicine

Elizabeth K Seng, Ph.D.
Phone: 718-430-3813

Backup Contact:


Location Contact:

Bronx, New York 10461
United States

Elizabeth Seng, Ph.D.
Phone: 929-224-3984

Site Status: Recruiting

Data Source:

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.